These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 24810722)
41. Interleukin-17 and cystic fibrosis lung disease. Brodlie M; Corris PA; Lordan J; Ward C Am J Respir Crit Care Med; 2012 Jan; 185(1):108-9; author reply 109-10. PubMed ID: 22210793 [No Abstract] [Full Text] [Related]
42. Progressive Scoliosis in a Child with Cystic Fibrosis. Castner LM; Nasr SZ; Arteta M Case Rep Pediatr; 2019; 2019():1471879. PubMed ID: 31093403 [TBL] [Abstract][Full Text] [Related]
43. Why cats cannot be sensitized to foreign proteins. AKCASU A Int Arch Allergy Appl Immunol; 1963; 22():85-6. PubMed ID: 14011507 [No Abstract] [Full Text] [Related]
44. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation. Quinn RA; Whiteson K; Lim YW; Salamon P; Bailey B; Mienardi S; Sanchez SE; Blake D; Conrad D; Rohwer F ISME J; 2015 Mar; 9(4):1052. PubMed ID: 25777574 [No Abstract] [Full Text] [Related]
45. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report. Walicka-Serzysko K; Sands D Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072 [TBL] [Abstract][Full Text] [Related]
46. Allergy in patients with cystic fibrosis. Yohe RM Ann Allergy; 1972 Nov; 30(11):627-31. PubMed ID: 5080739 [No Abstract] [Full Text] [Related]
47. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study]. da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019 [TBL] [Abstract][Full Text] [Related]
48. Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection. Hector A; Schäfer H; Pöschel S; Fischer A; Fritzsching B; Ralhan A; Carevic M; Öz H; Zundel S; Hogardt M; Bakele M; Rieber N; Riethmueller J; Graepler-Mainka U; Stahl M; Bender A; Frick JS; Mall M; Hartl D Am J Respir Crit Care Med; 2015 Apr; 191(8):914-23. PubMed ID: 25632992 [TBL] [Abstract][Full Text] [Related]
49. Severe pulmonary exacerbation in cystic fibrosis caused by cat allergy. Pabary R Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():29-31. PubMed ID: 24810722 [TBL] [Abstract][Full Text] [Related]
51. Update on treatment of pulmonary exacerbations in cystic fibrosis. Smyth A Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495 [TBL] [Abstract][Full Text] [Related]
52. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
53. [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children]. Breborowicz A Pol Merkur Lekarski; 2011 May; 30(179):349-51. PubMed ID: 21675140 [TBL] [Abstract][Full Text] [Related]
54. Adult patients' experiences of symptom management during pulmonary exacerbations in cystic fibrosis: A thematic synthesis of qualitative research. Schmid-Mohler G; Yorke J; Spirig R; Benden C; Caress AL Chronic Illn; 2019 Dec; 15(4):245-263. PubMed ID: 29742923 [No Abstract] [Full Text] [Related]